Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

ACRSACRS
Showing 5 of 13 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in ACLARIS THERAPEUTICS INC

Yes. RA Capital Management holds 12,723,026 shares of ACRS (Aclaris Therapeutics), worth $67.3M, as of its Q2 2026 13F filing. It increased the position by 5,918,954 shares (+87.0%) from Q1 2026. RA Capital Management has held ACRS since Q1 2026, across 2 quarterly 13F filings. ACRS is 0.6% of RA Capital Management's reported 13F portfolio.

Current Value

$67.3M

Current Shares

12.7M

Total Value Change

+$55.7M

Total Shares Change

+8.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12.7M
+87.0%
$67.3M0.6%$5.29
65
2026-Q1
New
6.8M
-
$25.5M0.3%$3.75
47
2025-Q2
Exited
0
-100.0%
$00.0%$1.42
0
2025-Q1
Unchanged
4.7M
0.0%
$7.1M0.1%$1.53
0
2024-Q4
New
4.7M
-
$11.6M0.2%$2.48
46

Other major holders of ACRS: WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used